Hi, what are you looking for?
Investing.com– Most Asian stocks edged higher on Wednesday tracking overnight rise on Wall Street, but gains were limited as investors remained cautious ahead of...
By David Shepardson and Jasper Ward (Reuters) – TikTok plans to keep paying U.S. employees even if the Supreme Court does not overturn a...
By Ismail Shakil OTTAWA (Reuters) -Canada on Tuesday approved with conditions U.S. grains merchant Bunge (NYSE:BG)’s $34 billion merger with Glencore-backed Viterra, clearing one...
ZURICH – beaconsmind Group (ISIN: CH0451123589 – Ticker: MLBMD), a Swiss provider of location-based marketing solutions, has completed a comprehensive infrastructure project for a...
Investing.com — Investment bank B. Riley Financial Inc (NASDAQ:RILY) has agreed to sell its appraisal and valuations unit to asset manager Oaktree Capital for...
(Reuters) – Elliott Investment Management has informed Southwest Airlines (NYSE:LUV) that it is requesting a special shareholder meeting, Bloomberg News reported on Monday, citing...
(Reuters) – Boeing (NYSE:BA) faces a crucial test with employees, customers and investors after announcing 10% job cuts and $5 billion in charges as...
Investing.com — Shares of Amer Sports (NYSE:AS) fell 3.5% in pre-open trade on Monday, following a downgrade from Wells Fargo, which revised its rating...
By Nick Carey PARIS (Reuters) -Chinese and European automakers went head-to-head at the Paris car show on Monday, with tensions running high as the...
Investing.com – India stocks were higher after the close on Monday, as gains in the Real Estate, Banking and Technology sectors led shares higher....
(Reuters) – Catalent (NYSE:CTLT) has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug...
(Reuters) – General Motors (NYSE:GM) and Barclays have signed a long-term credit card partnership agreement, the companies said on Monday. This post appeared first...
(Reuters) -Denmark’s H Lundbeck A/S has agreed to buy Longboard Pharmaceuticals in a $2.6 billion deal to boost its pipeline of treatments for neuro-rare...